What is ACT's health score?

Enact Holdings, Inc. (ACT) has a TradeApes health score of 61 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ACT's estimated fair value?

Based on our 5-year discounted cash flow model, Enact Holdings, Inc.'s estimated fair value is $113.75 per share, representing a 172.2% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ACT undervalued or overvalued?

Our model currently rates ACT as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ACT... Refresh in a moment for the full analysis.

Enact Holdings, Inc. (ACT)

Financials Undervalued medium healthy

$41.79

Updated: 2026-06-06

TradeApes Score

Financial Strength

55 Mixed

Operating Trend

50 Mixed

Relative Value

75 Strong

Capital Allocation

55 Mixed

Risk

80 Strong

Est. Fair Value $113.75

DCF Upside +172.2%

Sector Rank #2665 of 6140

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Piotroski F-Score 0–3 — multiple financial weakness signals

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.